Clinical Trials Directory

Trials / Sponsors / Huabo Biopharm Co., Ltd.

Huabo Biopharm Co., Ltd.

Industry · 14 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
Enrolling By InvitationA Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC
TNBC
Phase 22025-08-14
RecruitingA Phase 2 Study of HB0017 in Psoriasis Patients
Psoriasis (PsO)
Phase 22024-09-30
RecruitingStudy of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis
Psoriasis
Phase 32024-03-01
RecruitingA Study to Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor
Advanced NSCLC, Advanced Endometrial Cancer
Phase 1 / Phase 22024-01-31
UnknownA Study of HB0025 Injection in Patients With Advanced Renal Cancer
Renal Cancer
Phase 22023-01-30
CompletedA Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Phase 22022-10-25
UnknownA Study of HB0030 Injection in Patients With Advanced Solid Tumors
Advanced Solid Tumor
Phase 12021-12-21
CompletedA Study of HB0017 in Patients With Moderate to Severe Plaque Psoriasis
Plaque Psoriasis
Phase 12021-09-02
UnknownA Study of of HOT1030 in Patients With Advanced Solid Tumors
Solid Tumor, Adult
Phase 12021-03-12
UnknownA Study of Injection HB0025 in Patients With Advanced Solid Tumors
Tumor, Subjects
Phase 12021-03-10
CompletedA Study of Injection HB0017 in Adult Healthy Volunteers
Healthy Subjects
Phase 12020-10-02
UnknownA Study of HB002.1T Plus Chemotherapy in Subjects With Solid Tumor
Solid Tumor
Phase 12020-04-28
CompletedA Study of Injection HB002.1T in Subjects With Solid Tumor
Solid Tumor
Phase 12018-06-28
CompletedA Study of Single Intravitreal Injection HB002.1M in Subjects With Neovascular Age-Related Macular Degeneratio
Neovascular Age-Related Macular Degeneration
Phase 12018-02-08